- Q1 2024 Alnylam Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2024$150.31 (+0.23%)Earnings
- Q4 2023 Alnylam Pharmaceuticals Inc Earnings Call TranscriptFeb 15, 2024$147.43 (-10.19%)Earnings
- Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Alnylam Pharmaceuticals Inc R&D Day TranscriptDec 13, 2023
- Alnylam Pharmaceuticals Inc at Piper Sandler Healthcare Conference TranscriptNov 29, 2023
- Alnylam Pharmaceuticals Inc at Stifel Healthcare Conference TranscriptNov 14, 2023
- Alnylam Pharmaceuticals Inc at Jefferies London Healthcare Conference TranscriptNov 14, 2023
- Q3 2023 Alnylam Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2023$161.53 (+2.89%)Earnings
- Alnylam Pharmaceuticals Inc To Host Investor Call TranscriptOct 09, 2023
- Alnylam Pharmaceuticals Inc at Canaccord Genuity Growth Conference TranscriptAug 10, 2023
- Q2 2023 Alnylam Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2023$190.1 (+1.65%)Earnings
- Alnylam Pharmaceuticals Inc to Discuss Collaboration with Roche TranscriptJul 24, 2023
- Alnylam Pharmaceuticals Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Alnylam Pharmaceuticals Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Alnylam Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2023$205.39 (+2.95%)Earnings
- Alnylam Pharmaceuticals Inc ALN-APP Call TranscriptApr 26, 2023
- Alnylam Pharmaceuticals Inc at Ginkgo Bioworks Ferment Conference TranscriptApr 19, 2023
- Alnylam Pharmaceuticals Inc at Stifel CNS Days (Virtual) TranscriptMar 29, 2023
- Alnylam Pharmaceuticals Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2023
- Alnylam Pharmaceuticals Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 15, 2023
- Alnylam Pharmaceuticals Inc at Cowen Health Care Conference TranscriptMar 08, 2023
- Q4 2022 Alnylam Pharmaceuticals Inc Earnings Call TranscriptFeb 23, 2023$196.24 (-2.42%)Earnings
- Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Alnylam Pharmaceuticals Inc R&D Day TranscriptDec 15, 2022
- Alnylam Pharmaceuticals Inc at Piper Sandler Healthcare Conference TranscriptNov 30, 2022
- Alnylam Pharmaceuticals Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Alnylam Pharmaceuticals Inc at Stifel Healthcare Conference TranscriptNov 16, 2022
- Alnylam Pharmaceuticals Inc at Jefferies London Healthcare Conference TranscriptNov 16, 2022
- Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: CNS Delivery and ALN-APP, in Development for the Treatment of Alzheimer's Disease and Cerebral Amyloid Angiopathy TranscriptNov 01, 2022
- Q3 2022 Alnylam Pharmaceuticals Inc Earnings Call TranscriptOct 27, 2022$194 (-3.49%)Earnings
- Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Alnylam Engine for Sustainable Innovation: Leadership in RNAi Platform and Human Genetics TranscriptOct 21, 2022
- Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Results at HFSA Scientific Meeting TranscriptOct 01, 2022
- Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Cemdisiran, in Development for the Treatment of IgA Nephropathy (IgAN) and Other Complement-Mediated Diseases TranscriptSep 27, 2022
- Alnylam Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Results - Conference Call TranscriptSep 08, 2022
- Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Topline Results TranscriptAug 03, 2022
- Q2 2022 Alnylam Pharmaceuticals Inc Earnings Call TranscriptJul 28, 2022$143.52 (+1.09%)Earnings
- Alnylam Pharmaceuticals Inc to Discuss FDA Approval of AMVUTTRA (Vutrisiran) TranscriptJun 14, 2022
- Alnylam Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2022
- Alnylam Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Alnylam Pharmaceuticals Inc at UBS Global Healthcare Conference TranscriptMay 25, 2022
- Alnylam Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptMay 24, 2022
- Alnylam Pharmaceuticals Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Alnylam Pharmaceuticals Inc Earnings Call TranscriptApr 28, 2022$143.16 (-7.59%)Earnings
- Alnylam Pharmaceuticals Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2022
- Alnylam Pharmaceuticals Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Alnylam Pharmaceuticals Inc at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Alnylam Pharmaceuticals Inc at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 17, 2022
- Q4 2021 Alnylam Pharmaceuticals Inc Earnings Call TranscriptFeb 10, 2022$150.86 (-0.36%)Earnings
- Alnylam Pharmaceuticals Inc to Present HELIOS-A 18-Month Results - Conference Call TranscriptJan 21, 2022
- Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Alnylam Pharmaceuticals Inc at Piper Sandler Healthcare Conference (Virtual) TranscriptDec 02, 2021
- Alnylam Pharmaceuticals Inc at Evercore ISI HealthCONx Virtual Conference TranscriptNov 30, 2021
- Alnylam Pharmaceuticals Inc Virtual R&D Day TranscriptNov 19, 2021
- Q3 2021 Alnylam Pharmaceuticals Inc Earnings Call TranscriptOct 28, 2021$162.14 (-15.18%)Earnings
- Alnylam Pharmaceuticals Inc at Chardan Genetic Medicines Conference (Virtual) TranscriptOct 05, 2021
- Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: CNS & Extrahepatic RNAi Pipeline Programs TranscriptOct 01, 2021
- Alnylam Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 28, 2021
- Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Liver-Directed RNAi Pipeline Programs TranscriptSep 20, 2021
- Alnylam Pharmaceuticals Inc at Bank of America Global Healthcare Conference (Virtual) TranscriptSep 16, 2021
- Alnylam Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 13, 2021
- Alnylam Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Lumasiran, for the Treatment of Primary Hyperoxaluria Type 1 TranscriptAug 19, 2021
- Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Givosiran, for the Treatment of Acute Hepatic Porphyria TranscriptAug 04, 2021
- Q2 2021 Alnylam Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2021$178.81 (+0.48%)Earnings
- Alnylam Pharmaceuticals Inc "RNAi Roundtable" Webcast Series: Patisiran & Vutrisiran, in Development for the Treatment of ATTR Amyloidosis TranscriptJul 16, 2021
- Alnylam Pharmaceuticals Inc "RNAi Roundtable” Webcast Series: ALN-AGT, in Development for the Treatment of Hypertension TranscriptJun 30, 2021
- Alnylam Pharmaceuticals Inc at Nasdaq Investor Conference (Virtual) TranscriptJun 15, 2021
- Alnylam Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Alnylam Pharmaceuticals Inc at Sanford C Bernstein Strategic Decisions Conference (Virtual) TranscriptJun 03, 2021
- Alnylam Pharmaceuticals Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- Alnylam Pharmaceuticals Inc at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Alnylam Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMay 18, 2021
- Alnylam Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Q1 2021 Alnylam Pharmaceuticals Inc Earnings Call TranscriptApr 29, 2021$139.69 (-2.68%)Earnings
- Alnylam Pharmaceuticals Inc to Discuss Full 9-Month Results from the HELIOS-A Phase 3 Study of Vutrisiran - Corporate Call TranscriptApr 19, 2021
- Alnylam Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) TranscriptApr 13, 2021
- Alnylam Pharmaceuticals Inc at Stifel CNS Day TranscriptApr 01, 2021
- Alnylam Pharmaceuticals Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Alnylam Pharmaceuticals Inc at H C Wainwright Global Life Sciences Conference (Virtual) TranscriptMar 09, 2021
- Alnylam Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Alnylam Pharmaceuticals Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- Q4 2020 Alnylam Pharmaceuticals Inc Earnings Call TranscriptFeb 11, 2021$165.38 (+0.74%)Earnings
- Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Alnylam Pharmaceuticals Inc to Discuss Topline HELIOS-A Phase 3 Results of Vutrisiran - Conference Call TranscriptJan 07, 2021
- Alnylam Pharmaceuticals Inc R&D Day 2020 (Event 2) TranscriptDec 16, 2020
- Alnylam Pharmaceuticals Inc R&D Day 2020 (Event 1) TranscriptDec 15, 2020
- Alnylam Pharmaceuticals Inc at Nasdaq Virtual Investor Conference TranscriptDec 04, 2020
- Alnylam Pharmaceuticals Inc to Discuss FDA Approval of OXLUMO (Lumasiran) Conference Call TranscriptNov 24, 2020
- Alnylam Pharmaceuticals Inc at Stifel Virtual Healthcare Conference TranscriptNov 16, 2020
- Alnylam Pharmaceuticals Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- Q3 2020 Alnylam Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020$137.86 (-1.17%)Earnings
- Alnylam Pharmaceuticals Inc at H C Wainwright Hepatitis B Virus (HBV) Mini-Conference (Virtual) TranscriptOct 20, 2020
- Alnylam Pharmaceuticals Inc at Chardan Genetic Medicines Conference (Virtual) TranscriptOct 05, 2020
- Alnylam Pharmaceuticals Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Alnylam Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Alnylam Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Alnylam Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2020
- BridgeBio Pharma Inc at Citi BioPharma Conference (Virtual)- Panel: TTR Amyloidosis TranscriptSep 09, 2020
- Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Patisiran & Vutrisiran, in Development for the Treatment of Transthyretin-Mediated Amyloidosis TranscriptSep 03, 2020
- Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Lumasiran, in Development for the Treatment of Primary Hyperoxaluria Type I TranscriptAug 10, 2020
- Q2 2020 Alnylam Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2020$144.12 (-4.20%)Earnings
- Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Early Stage RNAi Therapeutics Pipeline TranscriptJul 17, 2020
- Alnylam Pharmaceuticals Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) TranscriptJun 24, 2020
- Alnylam Pharmaceuticals Inc "RNAi Roundtable” Webcast Series: ALN-AGT, in Development for the Treatment of Hypertension TranscriptJun 23, 2020
- Alnylam Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- Alnylam Pharmaceuticals Inc to Discuss Full Results from ILLUMINATE-A Phase 3 Study of Lumasiran at ERA-EDTA International Congress TranscriptJun 07, 2020
- Alnylam Pharmaceuticals Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- Alnylam Pharmaceuticals Inc at UBS Global Healthcare Conference (Virtual) TranscriptMay 20, 2020
- Alnylam Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Alnylam Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMay 06, 2020
- Q1 2020 Alnylam Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2020$145.27 (+2.86%)Earnings
- Alnylam Pharmaceuticals Inc at Needham Healthcare Conference TranscriptApr 14, 2020
- Alnylam Pharmaceuticals Inc Conference Call to Discuss Strategic Financing Collaboration with Blackstone TranscriptApr 13, 2020
- Alnylam Pharmaceuticals Inc at Barclays Global Healthcare Conference TranscriptMar 10, 2020
- Alnylam Pharmaceuticals Inc at Cowen HealthCare Conference TranscriptMar 03, 2020
- Alnylam Pharmaceuticals Inc at Leerink Global Healthcare Conference TranscriptFeb 27, 2020
- Q4 2019 Alnylam Pharmaceuticals Inc Earnings Call TranscriptFeb 06, 2020$121.96 (+0.30%)Earnings
- Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Alnylam Pharmaceuticals Inc to Discuss Topline Results from ILLUMINATE-A Phase 3 Study of Lumasiran Conference Call TranscriptDec 17, 2019
- Alnylam Pharmaceuticals Inc at Piper Jaffray Healthcare Conference TranscriptDec 05, 2019
- Alnylam Pharmaceuticals Inc at Evercore HealthCONx Conference TranscriptDec 04, 2019
- Alnylam Pharmaceuticals Inc R&D Day 2019 TranscriptNov 22, 2019
- Alnylam Pharmaceuticals Inc Conference Call to Discuss FDA Approval of GIVLAARI (Givosiran) TranscriptNov 20, 2019
- Alnylam Pharmaceuticals Inc at Stifel Healthcare Conference TranscriptNov 19, 2019
- Q3 2019 Alnylam Pharmaceuticals Inc Earnings Call TranscriptOct 31, 2019$86.74 (-0.61%)Earnings
- Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Lumasiran, in Development for the Treatment of Primary Hyperoxaluria Type 1 TranscriptOct 10, 2019
- Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Givosiran, in Development for the Treatment of Acute Hepatic Porphyria TranscriptOct 07, 2019
- Alnylam Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptOct 03, 2019
- Alnylam Pharmaceuticals Inc "RNAi Roundtable" Webcast Series: Patisiran & Vutrisiran, for the Treatment of Transthyretin-Mediated Amyloidosis TranscriptSep 16, 2019
- Alnylam Pharmaceuticals Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Alnylam Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2019$74.38 (+4.16%)Earnings
- Alnylam Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- Alnylam Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2019
- Alnylam Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 16, 2019
- Q1 2019 Alnylam Pharmaceuticals Inc Earnings Call TranscriptMay 01, 2019$83.03 (-7.06%)Earnings
- Alnylam Pharmaceuticals Inc Annual Shareholders Meeting TranscriptApr 25, 2019
- Alnylam Pharmaceuticals Inc to Present Givosiran Phase 3 Data at the European Association for the Study of the Liver (EASL) International Liver Congress Conference Call TranscriptApr 13, 2019
- Alnylam Pharmaceuticals Inc to Discuss Regeneron Collaboration - Call TranscriptApr 08, 2019
- Alnylam Pharmaceuticals Inc at Cowen Health Care Conference TranscriptMar 13, 2019
- Alnylam Pharmaceuticals Inc to Discuss Topline Results from ENVISION Phase 3 Study of Givosiran Conference Call TranscriptMar 06, 2019
- Alnylam Pharmaceuticals Inc at Leerink Partners Global Healthcare Conference TranscriptFeb 27, 2019
- Alnylam Pharmaceuticals Inc at Biotechnology Industry Organization (BIO) CEO & Investor Conference TranscriptFeb 11, 2019
- Q4 2018 Alnylam Pharmaceuticals Inc Earnings Call TranscriptFeb 07, 2019$80.8 (-1.17%)Earnings
Alnylam Pharmaceuticals Inc R&D Day 2020 (Event 2) Transcript
Good morning, and welcome to day 2 of our Virtual Alnylam R&D Day event. I'm Christine Lindenboom, Senior Vice President of investor relations and Corporate Communications at Alnylam. With me today are Dr. Arun Sanyal, Virginia Commonwealth University School of Medicine; and Josh Friedman, Senior Director of Clinical Research at Alnylam, who will discuss succeeding in NASH with genetically validated targets. Pushkal Garg, Chief Medical Officer at Alnylam, will cover progress from our earlier-stage clinical pipeline. Kevin Fitzgerald, Chief Scientific Officer at Alnylam, will discuss opportunities beyond the liver with RNAi therapeutics and we will close with an update on our path to a self-sustainable financial profile with Alnylam's CFO, Jeff Poulton.
Before I hand it over to Josh Freeman, I'd like to start with a few brief comments. Today's event is expected to run until approximately noon eastern standard time. Akshay will moderate a Q&A session at the conclusion of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)